Telemedicine Influence in the Follow up of the Type 2 Diabetes Patient
|Type 2 Diabetes Telemedicine Self Monitoring Blood Glucose Primary Care||Device: Telemedicine system|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
- HBA1c Glycosylated hemoglobin [ Time Frame: one year for every patient ]
- Blood glucose, Total Cholesterol, HDL Cholesterol,LDL Cholesterol, Triglycerides, BMI, systolic and diastolic blood pressure and system adherence [ Time Frame: one year for every patient ]
|Study Start Date:||October 2003|
|Study Completion Date:||June 2005|
|No Intervention: Control group|
|Active Comparator: Telemedicine group||
Device: Telemedicine system
Possibility of sending the SMBG values of the patients to a web page via phone mobile sms messages. The HCP had a password access to this web page to check the blood glucose values of the patients and if necessary send to them sms messages with recommendations.
The UKPDS study in type 2 diabetes and the DCCT in type 1, showed that intensive blood glucose control and the following HBA1c decrease were associated with a decrease of diabetic complications. Introducing telecontrol elements in the real time follow up of the patients, should help to know continuously patient blood glucose profile and add if necessary immediately therapeutical variations, to maintain HbA1c levels as low as possible.
The study compares type 2 diabetes patients performing self monitoring of blood glucose, followed up by their family doctor in their primary care unit with the extra support of a real time teleassistance system with type 2 diabetes patients performing self monitoring of blood glucose, followed up by their family doctor in their primary care unit.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00527254
|Province of Malaga Health Department|
|Málaga, Spain, 29001|
|Principal Investigator:||Maria Isabel Rodríguez Idígoras, Doctor||Málaga Health Department (Junta de Andalucia)|